Heart function disturbances in chronic kidney disease - Echocardiographic indices

Archives of Medical Science

Volumn 10, Issue 6, 2014, Pages 1109-1116

  Franczyk Skóra, Beata ^a   Gluba, Anna ^a   Olszewski, Robert ^b   Banach, MacIej ^a   Rysz, Jacek ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b MILITARY INSTITUTE OF MEDICINE   (Poland)

Author keywords

Chronic kidney disease; Diastolic dysfunction; Heart failure; Indices

Indexed keywords

ADULT; AGED; ARTICLE; CAMERA; CHRONIC KIDNEY DISEASE; FEMALE; GLOMERULUS FILTRATION RATE; HEART FUNCTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE MASS; HUMAN; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PULMONARY VEIN; TRANSTHORACIC ECHOCARDIOGRAPHY; VEIN BLOOD FLOW;

EID: 84919966723     PISSN: 17341922     EISSN: 18969151     Source Type: Journal    
DOI: 10.5114/aoms.2014.47822     Document Type: Article

References (51)

1. Pabst S, Hammerstingl C, Hundt F, et al. Pulmonary hypertension in patients with chronic kidney disease on dialysis and without dialysis: results of the PEPPER-Study. PLoS ONE 2012; 7: e35310.
2. Hatta T, Nishimura S, Nishimura T. Prognostic risk strat-ifcation of myocardial ischemia evaluated by gated myocardial perfusion SPECT in patients with chronic kidney disease. Eur J Nucl Med Mol Imaging 2009; 36: 1835-41.
3. Franczyk-Skóra B, Gluba A, Banach M, Rysz J. Treatment of non-ST-elevation myocardial infarction and ST-eleva-tion myocardial infarction in patients with chronic kidney disease. Arch Med Sci 2013; 9: 1019-27.
4. Athyros VG, Katsiki N, Tziomalos K, et al.; GREACE Study Collaborative Group. Statins and cardiovascular outcomes in elderly and younger patients with coronary artery disease: a post hoc analysis of the GREACE study. Arch Med Sci 2013; 9: 418-26.
5. Kim MK, Kim B, Lee JY, et al. Tissue Doppler-derived E/E' ratio as a parameter for assessing diastolic heart failure and as a predictor of mortality in patients with chronic kidney disease. Korean J Intern Med 2013; 28: 35-44.
6. Hung MJ, Yang NI, Wu IW, et al. Three-dimensional echocardiographic assessment of left ventricular remodeling in predialysis chronic kidney disease patients. J Nephrol 2012; 25: 96-106.
7. Otsuka T, Suzuki M, Yoshikawa H, Sugi K. Left ventricular diastolic dysfunction in the early stage of chronic kidney disease. J Cardiol 2009; 54: 199-204.
8. Gluba-Brzózka A, Michalska-Kasiczak M, Franczyk-Skó-ra B, Nocuń M, Banach M, Rysz J. Markers of increased cardiovascular risk in patients with chronic kidney disease. J Lipids Health Dis 2014; 13: 135.
9. Hida S, Chikamori T, Tanaka H, et al. Diagnostic value of left ventricular function after adenosine triphosphate loading and at rest in the detection of multi-vessel coronary artery disease using myocardial perfusion imaging. J Nucl Cardiol 2009; 16: 20-7.
10. Masugata H, Senda S, Goda F, et al. Echocardiographic assessment of the cardio-renal connection: is left ventricular hypertrophy or diastolic function more closely correlated with estimated glomerular fltration rate in patients with cardiovascular risk factors? Clin Exp Hy-pertens 2010; 32: 113-20.
11. Sato W, Kosaka T, Koyama T, et al. Impaired renal function is a major determinant of left ventricular diastolic dysfunction: assessment by stress myocardial perfusion imaging. Ann Nucl Med 2013; 27: 729-36.
12. Martin FL, McKie PM, Cataliotti A, et al. Experimental mild renal insufciency mediates early cardiac apopto-sis, fbrosis, and diastolic dysfunction: a kidney-heart connection. Am J Physiol Regul Integr Comp Physiol 2012; 302: R292-9.
13. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray D, Barre PE. Outcome and risk factors of ischemic heart disease in chronic uremia. Kidney Int 1996; 49: 1428-34.
14. Zoccali C, Benedetto FA, Mallamaci F, et al. Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression. Kidney Int 2004; 65: 1492-8.
15. Miyazato J, Horio T, Takiuchi S, et al. Left ventricular di-astolic dysfunction in patients with chronic renal failure: impact of diabetes mellitus. Diabet Med 2005; 22: 730-6.
16. Agarwal S, Dangri P, Kalra O P, Rajpal S. Echocardiograph-ic assessment of cardiac dysfunction in patients of chronic renal failure. JIACM 2003; 4: 296-303.
17. Hayashi SY, Rohani M, Lindholm B, et al. Left ventricular function in patients with chronic kidney disease evaluated by colour tissue Doppler velocity imaging. Nephrol Dial Transplant 2006; 21: 125-32.
18. McGregor E, Jardine AG, Murray LS, et al. Pre-operative echocardiographic abnormalities and adverse outcome following renal transplantation. Nephrol Dial Transplant 1998; 13: 1499-505.
19. Olechnowicz-Tietz S, Gluba A, Paradowska A, Banach M, Rysz J. The risk of atherosclerosis in patients with chronic kidney disease. Int Urol Nephrol 2013; 45: 1605-12.
20. Banach M, Serban C, Aronow WS, et al. Lipid, blood pressure and kidney update 2013. Int Urol Nephrol 2014; 46: 947-61.
21. Sharma R, Pellerin D, Gaze DC, et al. Mitral peak Dop-pler E-wave to peak mitral annulus velocity ratio is an accurate estimate of left ventricular flling pressure and predicts mortality in end-stage renal disease. J Am Soc Echocardiogr 2006; 19: 266-73.
22. Barberato SH, Pecoits-Filho R. Usefulness of left atrial volume for the diferentiation of normal from pseudonormal diastolic function pattern in patients on hemo-dialysis. J Am Soc Echocardiogr 2007; 20: 359-65.
23. Yun KH, Kang DG, Kim KH, et al. The usefulness of colour M-mode Doppler echocardiographic indices in the assessment of left ventricular diastolic function. Korean Circ J 2004; 34: 1082-9.
24. Dokainish H, Zoghbi WA, Lakkis NM, et al. Optimal non-invasive assessment of left ventricular flling pressures: a comparison of tissue Doppler echocardiography and B-type natriuretic peptide in patients with pulmonary artery catheters. Circulation 2004; 109: 2432-9.
25. Pecková M, Charvat J, Schuck O, Hill M, Svab P, Horacko-va M. The association between left ventricular diastolic function and a mild-to-moderate decrease in glomeru-lar fltration rate in patients with type 2 diabetes melli-tus. J Int Med Res 2011; 39: 2178-86.
26. Levey AS, Astor BC, Stevens LA, et al. Chronic kidney disease, diabetes, and hypertension: what's in a name? Kidney Int 2010; 78: 19-22.
27. Innelli P, Sanchez R, Marra F, et al. The impact of aging on left ventricular longitudinal function in healthy subjects: a pulsed tissue Doppler study. Eur J Echocardiogr 2008; 9: 241-9.
28. Barberato SH, Mantilla DE, Misocami MA, et al. Efect of preload reduction by hemodialysis on left atrial volume and echocardiographic Doppler parameters in patients with end stage renal disease. Am J Cardiol 2004; 94: 1208-10.
29. Appleton C P, Hatle LK. The natural history of left ventricular flling abnormalities: assessment by two dimensional and Doppler echocardiography. Echocardiography 1992; 9: 437-57.
30. London GM. Cardiovascular disease in chronic renal failure: pathophysiologic aspects. Semin Dial 2003; 16: 85-94.
31. Crews DC, Plantinga LC, Miller ER 3rd, et al. Prevalence of chronic kidney disease in persons with undiagnosed or prehypertension in the United States. Hypertension 2010; 55: 1102-9.
32. Pecoits-Filho R, Barberato SH. Echocardiography in chronic kidney disease: diagnostic and prognostic implications. Nephron Clin Pract 2010; 114: c242-7.
33. Dougherty AH, Naccarelli GV, Gray EL, Hicks CH, Goldstein RA. Congestive heart failure with normal systolic function. Am J Cardiol 1984; 54: 778-82.
34. Soufer R, Wohlgelernter D, Vita NA, et al. Intact systolic left ventricular function in clinical congestive heart failure. Am J Cardiol 1985; 55: 1032-6.
35. Aronow WS. What should the optimal blood pressure goal be in patients with diabetes mellitus or chronic kidney disease? Arch Med Sci 2012; 8: 399-402.
36. Feola M, Lombardo E, Testa M, Avogadri E, Piccolo S, Vado A. Prognostic factors of mid-term clinical outcome in congestive heart failure patients discharged after acute decompensation. Arch Med Sci 2012; 8: 462-70.
37. Kunz K, Dimitrov Y, Muller S, Chantrel F, Hannedouche T. Uraemic cardiomyopathy. Nephrol Dial Transplant 1998; 13 (Suppl 4): 39-43.
38. Franczyk-Skóra B, Gluba A, Banach M, Rozentryt P, Poloński L, Rysz J. Acute coronary syndromes in patients with chronic kidney disease. Curr Vasc Pharmacol 2013; 11: 758-67.
39. Franczyk-Skóra B, Gluba A, Banach M, Kozłowski D, Małyszko J, Rysz J. Prevention of sudden cardiac death in patients with chronic kidney disease. BMC Nephrol 2012; 13: 162.
40. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 1995; 5: 2024-31.
41. Foley RN, Parfrey PS, Harnett JD, et al. Clinical and echo-cardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995; 47: 186-92.
42. London GM, Pannier B, Guerin A P, et al. Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. J Am Soc Nephrol 2001; 12: 2759-67.
43. Levin A, Singer J, Thompson CR, Ross H, Lewis M. Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am J Kidney Dis 1996; 27: 347-54.
44. London GM, Parfrey PS. Cardiac disease in chronic uremia: pathogenesis. Adv Ren Replace Ther 1997; 4: 194-211.
45. Ori Y, Korzets A, Katz M, Perek Y, Zahavi I, Gafter U. Hae-modialysis arteriovenous access: a prospective haemo-dynamic evaluation. Nephrol Dial Transplant 1996; 11: 94-7.
46. London GM, Guerin A P, Marchais SJ. Hemodynamic overload in end-stage renal disease patients. Semin Dial 1999; 12: 7-83.
47. Duran M, Unal A, Inanc MT, Esin F, Yilmaz Y, Ornek E. Efect of maintenance hemodialysis on diastolic left ventricular function in end-stage renal disease. Clinics 2010; 65: 979-84.
48. Rosello A, Torregrosa I, Solis MA. Study of diastolic function in peritoneal dialysis patients. Comparison between pulsed and Tissue Doppler. Nefrologia 2007; 27: 482-8.
49. Colantonio LD, Baber U, Banach M, et al. Contrasting cholesterol management guidelines for adults with CKD. J Am Soc Nephrol in press; doi: 10.1681/ASN.2014040400.
50. Cicero A F, Reggi A, Parini A, Borghi C. Application of polyunsaturated fatty acids in internal medicine: beyond the established cardiovascular efects. Arch Med Sci 2012; 8: 784-93.
51. Banach M, Mikhailidis D P, Kjeldsen SE, Rysz J. Time for new indications for statins? Med Sci Monit 2009; 15: MS1-5.